FindTrial
Sign In

Usefulness of Artificial intelligence for the Screening of High-risk Groups of the Pancreatic Cancer

Usefulness of Artificial intelligence for the Screening of High-risk Groups of the Pancreatic Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094459
Enrollment
Unknown
Registered
2024-12-23
Start date
2024-12-24
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Target disease:pancreatic cystic neoplasm

Interventions

Observation group :None

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 95 Years

Inclusion criteria

Inclusion criteria: 1) Patients with pancreatic lPMN/MCN/SCN/SPT confirmed by pathology; 2) The patient underwensurgery within 3 months after the CT scan of the "pancreatic protocol" and obtained postoperativepathological data.

Exclusion criteria

Exclusion criteria: (1) Patients with no confirmed pathological diagnosis of pancreatic IPMN/MCN/SCN/SPN (2) Patients with a time of more than 3 months between imaging and surgery/puncture (3) Patients with severe artifacts in CT images

Design outcomes

Primary

MeasureTime frame
CT;Image quantization and feature extraction;—

Countries

China

Contacts

Public Contactyun bian

Shanghai Changhai Hospital

bianyun2012@foxmail.com+86 138 1635 7024

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026